BioInquire Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

BioInquire General Information


Developer of a bioinformatics analysis platform designed to help researchers analyze mass spectrometric data from proteomic and glycomic experiments. The company's platform offers a comprehensive suite of tools that provides support throughout the full data analysis pipeline, from statistical validation to quantification, enabling researchers to derive meaningful data from the massive amounts of information generated by complex proteomic and glycomic experiments.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Business/Productivity Software
Primary Office
  • 220 Riverbend Road
  • Suite 103
  • Athens, GA 30602
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioInquire Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 04-Sep-2012 Completed Out of Business
2. Later Stage VC 01-Mar-2023 Completed Profitable
1. Merger/Acquisition 17-Feb-2010 $3M 000 Completed Profitable
To view BioInquire’s complete valuation and funding history, request access »